Normal view MARC view ISBD view

Formulation development and risk assessment for fixed dose combination contains tolbutamide & voglibose for treating type II diabetes mellotus.

ANUSHA, Cheparthi

Formulation development and risk assessment for fixed dose combination contains tolbutamide & voglibose for treating type II diabetes mellotus. - iv,99

Print
Add to your cart (remove)
Send to device
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)